Redirecting to https://www.manilatimes.net/2026/05/31/tmt-newswire/pr-newswire/dizal-presents-positive-nsclc-data-for-fourth-generation-egfr-tki-dzd6008-and-golidocitinib-in-combination-with-anti-pd-1-at-asco-2026/2355084